Seeking Alpha

arthurs1

arthurs1
Send Message
View as an RSS Feed
View arthurs1's Comments BY TICKER:
Latest  |  Highest rated
  • PTC Therapeutics Looks Like A High-Risk Play On Rare Diseases [View article]
    The father of one patient on the ISIS drug has a blog. He has reported outstanding improvement in his daughter in multiple areas. He is so happy she is now getting the higher 12 mg dose. New data will be reported on April 26. Stay tuned and God bless these children.
    Apr 12 04:47 PM | 1 Like Like |Link to Comment
  • Idera slumps [View news story]
    Pran's results can at best be labeled mixed. Overall little or no improvement. One category out of 8 showed improvement.
    Mar 24 11:33 PM | Likes Like |Link to Comment
  • Galena Biopharma, Inc. EPS of -$0.46 [View news story]
    Have you ever heard of an unofficial SEC investigation?
    It's kind of like being a little bit pregnant.
    Mar 17 09:47 PM | 3 Likes Like |Link to Comment
  • Galena Biopharma, Inc. EPS of -$0.46 [View news story]
    Smack down!
    Mar 17 09:45 PM | 2 Likes Like |Link to Comment
  • Tekmira Announces Proposed Public Offering of Common Stock [View article]
    Not wasting any time selling into the froth. Must be counting their lucky stars.
    Mar 10 06:51 PM | Likes Like |Link to Comment
  • It's Always Darkest Before The Dawn: Why Vivus Could Double In Three Months And Triple In Twelve [View article]
    Mojo your statement that Q has significant health risks is not true or at the very least not known. It did not surprise me at all then to hear you pump Arena. Only an Arena pumper would say such a thing.
    Any year now Arena stock may get back to where it was years ago. But I've been hearing about how great Arena is for years now, too bad for Arena pumpers the market has disagreed.
    Mar 3 06:14 PM | 1 Like Like |Link to Comment
  • It's Always Darkest Before The Dawn: Why Vivus Could Double In Three Months And Triple In Twelve [View article]
    The two drugs that are combined to make Q have been on the market for many, many years and at higher doses. The Arena drug is a completely new entity . That is why Q is the safer drug. You have long term safety data.
    Someday after many years that could change, but until then the Arena has not proven long term safety.
    Mar 3 05:53 PM | Likes Like |Link to Comment
  • Ico Therapeutics: Near-Term Catalyst Presents Enormous Upside [View article]
    Antisense has been proven to work time and time again by the founding father of antisense tchnology http://www.isispharm.com
    ICO licensed it's antisense technology from ISIS and ISIS owns 5 million shares at last report.
    Feb 26 01:41 PM | 1 Like Like |Link to Comment
  • Isis Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days [View article]
    What happened to Jetman's most recent comments? And mine? Something fishy going on here?
    Dec 28 05:53 PM | 1 Like Like |Link to Comment
  • Isis Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days [View article]
    My message above was for deltatov.
    Dec 28 05:43 PM | Likes Like |Link to Comment
  • Isis Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days [View article]
    Anyone shorting ISIS before shorting ALNY doesn't have knowledge of the facts. Shorting ISIS for more than a few points has been a very poor trade. And shorting ISIS more often than not a losing trade. I await a 10 to 20 point one day pop in the stock and it could happen more than once in 2014. ISIS should trade at a 100% premium to ALNY at a minimum right now.
    Dec 28 05:11 PM | 1 Like Like |Link to Comment
  • Isis Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days [View article]
    These insiders are not billionaires not even close and you referred to only one billionaire, and some would say a very eccentric billionaire. So what you really are telling us or showing us, is that insider selling has significantly dropped this qtr. A much better title of your article would have been,

    ISIS INSIDER SELLING DROPS BY OVER 90% IN 4TH QUARTER
    Dec 26 07:56 PM | 1 Like Like |Link to Comment
  • Isis Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days [View article]
    Short interest for the period ending 12/13 dropped by just over 725,000 shares to 10,814,738 million, the lowest number in over a year.

    http://bit.ly/K8nkZ3
    Dec 26 04:29 PM | 2 Likes Like |Link to Comment
  • Isis Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days [View article]
    Margin debt should go up with the market. If one wants to leverage 10 % of investments, the margin debt goes up with the capital gains but the leverage ratio doesn't. So even though debt increases by 10% on the gains equity increases 90%.
    Don't forget margin is used for bond and commodity ETFs as well as funds that short and put options,
    Dec 26 04:11 PM | 2 Likes Like |Link to Comment
  • Isis Pharmaceuticals: 3 Different Insiders Have Sold Shares During The Last 30 Days [View article]
    And if Dr. Jetman and IV board members don't know the answer, he/they will eventually get it from the company.
    Dec 26 04:00 PM | 1 Like Like |Link to Comment
COMMENTS STATS
333 Comments
214 Likes